nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA9—kidney cancer	0.306	0.526	CbGaD
Indapamide—CA2—kidney cancer	0.275	0.473	CbGaD
Indapamide—CYP3A4—Everolimus—kidney cancer	0.0222	0.293	CbGbCtD
Indapamide—SLC12A3—collecting duct of renal tubule—kidney cancer	0.0204	0.265	CbGeAlD
Indapamide—CYP3A4—Temsirolimus—kidney cancer	0.015	0.198	CbGbCtD
Indapamide—SLC12A3—nephron—kidney cancer	0.00909	0.118	CbGeAlD
Indapamide—CYP3A4—Pazopanib—kidney cancer	0.00789	0.104	CbGbCtD
Indapamide—CA2—collecting duct of renal tubule—kidney cancer	0.00695	0.0903	CbGeAlD
Indapamide—CYP3A4—Erlotinib—kidney cancer	0.00563	0.0741	CbGbCtD
Indapamide—CYP3A4—Paclitaxel—kidney cancer	0.00515	0.0678	CbGbCtD
Indapamide—CYP3A4—Sorafenib—kidney cancer	0.00458	0.0603	CbGbCtD
Indapamide—CYP3A4—Vinblastine—kidney cancer	0.00452	0.0595	CbGbCtD
Indapamide—CYP3A4—Vincristine—kidney cancer	0.00444	0.0585	CbGbCtD
Indapamide—CYP3A4—Sunitinib—kidney cancer	0.00371	0.0488	CbGbCtD
Indapamide—KCNE1—renal system—kidney cancer	0.00361	0.0469	CbGeAlD
Indapamide—KCNE1—kidney—kidney cancer	0.00349	0.0453	CbGeAlD
Indapamide—KCNE1—gonad—kidney cancer	0.00324	0.0421	CbGeAlD
Indapamide—CYP3A4—Doxorubicin—kidney cancer	0.00278	0.0366	CbGbCtD
Indapamide—SLC12A3—nephron tubule—kidney cancer	0.00196	0.0255	CbGeAlD
Indapamide—CA7—renal system—kidney cancer	0.00182	0.0236	CbGeAlD
Indapamide—SLC12A3—renal system—kidney cancer	0.00178	0.0232	CbGeAlD
Indapamide—CA7—kidney—kidney cancer	0.00176	0.0229	CbGeAlD
Indapamide—SLC12A3—kidney—kidney cancer	0.00172	0.0224	CbGeAlD
Indapamide—SLC12A3—cortex of kidney—kidney cancer	0.00168	0.0218	CbGeAlD
Indapamide—KCNQ1—renal system—kidney cancer	0.00166	0.0215	CbGeAlD
Indapamide—KCNQ1—kidney—kidney cancer	0.0016	0.0208	CbGeAlD
Indapamide—CYP3A4—urine—kidney cancer	0.0016	0.0208	CbGeAlD
Indapamide—KCNQ1—cortex of kidney—kidney cancer	0.00156	0.0203	CbGeAlD
Indapamide—KCNQ1—cardiac atrium—kidney cancer	0.00148	0.0193	CbGeAlD
Indapamide—CA12—renal system—kidney cancer	0.00118	0.0154	CbGeAlD
Indapamide—CA12—kidney—kidney cancer	0.00114	0.0148	CbGeAlD
Indapamide—CA5B—gonad—kidney cancer	0.000951	0.0124	CbGeAlD
Indapamide—CA5B—cardiac atrium—kidney cancer	0.00095	0.0123	CbGeAlD
Indapamide—Furosemide—CA9—kidney cancer	0.000947	0.191	CrCbGaD
Indapamide—Metolazone—CA9—kidney cancer	0.000909	0.183	CrCbGaD
Indapamide—Furosemide—CA2—kidney cancer	0.000851	0.172	CrCbGaD
Indapamide—CA4—nephron tubule—kidney cancer	0.000805	0.0105	CbGeAlD
Indapamide—CA4—renal system—kidney cancer	0.000732	0.00951	CbGeAlD
Indapamide—Bumetanide—CA9—kidney cancer	0.000717	0.145	CrCbGaD
Indapamide—CA4—kidney—kidney cancer	0.000708	0.00919	CbGeAlD
Indapamide—Chlorthalidone—CA9—kidney cancer	0.000703	0.142	CrCbGaD
Indapamide—CA4—cortex of kidney—kidney cancer	0.000689	0.00895	CbGeAlD
Indapamide—CA2—nephron tubule—kidney cancer	0.000668	0.00867	CbGeAlD
Indapamide—CA4—cardiac atrium—kidney cancer	0.000656	0.00852	CbGeAlD
Indapamide—Chlorthalidone—CA2—kidney cancer	0.000632	0.127	CrCbGaD
Indapamide—CA2—renal system—kidney cancer	0.000607	0.00789	CbGeAlD
Indapamide—CA2—kidney—kidney cancer	0.000587	0.00762	CbGeAlD
Indapamide—CA2—cortex of kidney—kidney cancer	0.000572	0.00742	CbGeAlD
Indapamide—CA2—cardiac atrium—kidney cancer	0.000544	0.00706	CbGeAlD
Indapamide—CYP3A4—renal system—kidney cancer	0.000392	0.00509	CbGeAlD
Indapamide—CYP3A4—kidney—kidney cancer	0.000379	0.00492	CbGeAlD
Indapamide—Bumetanide—PTGS2—kidney cancer	0.000202	0.0408	CrCbGaD
Indapamide—CA12—Metabolism—ALAD—kidney cancer	7.67e-05	0.000983	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PGK1—kidney cancer	7.57e-05	0.00097	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC5A3—kidney cancer	7.57e-05	0.00097	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC5A3—kidney cancer	7.57e-05	0.00097	CbGpPWpGaD
Indapamide—CA7—Metabolism—PGK1—kidney cancer	7.57e-05	0.00097	CbGpPWpGaD
Indapamide—CA12—Metabolism—ST3GAL2—kidney cancer	7.48e-05	0.000959	CbGpPWpGaD
Indapamide—Discomfort—Paclitaxel—kidney cancer	7.47e-05	0.000407	CcSEcCtD
Indapamide—Fatigue—Gemcitabine—kidney cancer	7.47e-05	0.000407	CcSEcCtD
Indapamide—Gastrointestinal pain—Vincristine—kidney cancer	7.47e-05	0.000407	CcSEcCtD
Indapamide—CA5B—Metabolism—LDHB—kidney cancer	7.42e-05	0.000952	CbGpPWpGaD
Indapamide—CA7—Metabolism—LDHB—kidney cancer	7.42e-05	0.000952	CbGpPWpGaD
Indapamide—Dizziness—Sorafenib—kidney cancer	7.42e-05	0.000404	CcSEcCtD
Indapamide—Pain—Gemcitabine—kidney cancer	7.41e-05	0.000403	CcSEcCtD
Indapamide—Constipation—Gemcitabine—kidney cancer	7.41e-05	0.000403	CcSEcCtD
Indapamide—Nausea—Erlotinib—kidney cancer	7.41e-05	0.000403	CcSEcCtD
Indapamide—Dry mouth—Paclitaxel—kidney cancer	7.4e-05	0.000403	CcSEcCtD
Indapamide—Diarrhoea—Sunitinib—kidney cancer	7.39e-05	0.000402	CcSEcCtD
Indapamide—CA4—Metabolism—PPAT—kidney cancer	7.38e-05	0.000946	CbGpPWpGaD
Indapamide—CA4—Metabolism—GLIPR1—kidney cancer	7.38e-05	0.000946	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—SOD2—kidney cancer	7.35e-05	0.000942	CbGpPWpGaD
Indapamide—Ataxia—Doxorubicin—kidney cancer	7.34e-05	0.0004	CcSEcCtD
Indapamide—Asthenia—Dactinomycin—kidney cancer	7.33e-05	0.000399	CcSEcCtD
Indapamide—CA9—Metabolism—PDHB—kidney cancer	7.31e-05	0.000938	CbGpPWpGaD
Indapamide—CA12—Metabolism—ALDH1A1—kidney cancer	7.31e-05	0.000938	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—kidney cancer	7.3e-05	0.000936	CbGpPWpGaD
Indapamide—Malnutrition—Capecitabine—kidney cancer	7.29e-05	0.000397	CcSEcCtD
Indapamide—Erythema—Capecitabine—kidney cancer	7.29e-05	0.000397	CcSEcCtD
Indapamide—Dehydration—Doxorubicin—kidney cancer	7.26e-05	0.000395	CcSEcCtD
Indapamide—Oedema—Paclitaxel—kidney cancer	7.25e-05	0.000395	CcSEcCtD
Indapamide—Anaphylactic shock—Paclitaxel—kidney cancer	7.25e-05	0.000395	CcSEcCtD
Indapamide—Abdominal pain—Vincristine—kidney cancer	7.22e-05	0.000393	CcSEcCtD
Indapamide—Body temperature increased—Vincristine—kidney cancer	7.22e-05	0.000393	CcSEcCtD
Indapamide—Liver function test abnormal—Doxorubicin—kidney cancer	7.21e-05	0.000392	CcSEcCtD
Indapamide—Infection—Paclitaxel—kidney cancer	7.2e-05	0.000392	CcSEcCtD
Indapamide—Flatulence—Capecitabine—kidney cancer	7.18e-05	0.000391	CcSEcCtD
Indapamide—Dysgeusia—Capecitabine—kidney cancer	7.14e-05	0.000389	CcSEcCtD
Indapamide—Dizziness—Sunitinib—kidney cancer	7.14e-05	0.000389	CcSEcCtD
Indapamide—Feeling abnormal—Gemcitabine—kidney cancer	7.14e-05	0.000389	CcSEcCtD
Indapamide—Shock—Paclitaxel—kidney cancer	7.13e-05	0.000388	CcSEcCtD
Indapamide—Vomiting—Sorafenib—kidney cancer	7.13e-05	0.000388	CcSEcCtD
Indapamide—Abdominal pain upper—Doxorubicin—kidney cancer	7.13e-05	0.000388	CcSEcCtD
Indapamide—Orthostatic hypotension—Doxorubicin—kidney cancer	7.13e-05	0.000388	CcSEcCtD
Indapamide—Nervous system disorder—Paclitaxel—kidney cancer	7.11e-05	0.000387	CcSEcCtD
Indapamide—Hypokalaemia—Doxorubicin—kidney cancer	7.1e-05	0.000387	CcSEcCtD
Indapamide—Thrombocytopenia—Paclitaxel—kidney cancer	7.1e-05	0.000387	CcSEcCtD
Indapamide—Tachycardia—Paclitaxel—kidney cancer	7.08e-05	0.000385	CcSEcCtD
Indapamide—CA2—Metabolism—PPAT—kidney cancer	7.08e-05	0.000907	CbGpPWpGaD
Indapamide—CA2—Metabolism—GLIPR1—kidney cancer	7.08e-05	0.000907	CbGpPWpGaD
Indapamide—Rash—Sorafenib—kidney cancer	7.07e-05	0.000385	CcSEcCtD
Indapamide—Dermatitis—Sorafenib—kidney cancer	7.07e-05	0.000385	CcSEcCtD
Indapamide—Back pain—Capecitabine—kidney cancer	7.05e-05	0.000384	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.05e-05	0.000904	CbGpPWpGaD
Indapamide—Skin disorder—Paclitaxel—kidney cancer	7.04e-05	0.000384	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	7.03e-05	0.000383	CcSEcCtD
Indapamide—Headache—Sorafenib—kidney cancer	7.03e-05	0.000383	CcSEcCtD
Indapamide—CA12—Metabolism—PGK1—kidney cancer	7.01e-05	0.000899	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC5A3—kidney cancer	7.01e-05	0.000899	CbGpPWpGaD
Indapamide—Muscle spasms—Capecitabine—kidney cancer	7.01e-05	0.000382	CcSEcCtD
Indapamide—Hyperhidrosis—Paclitaxel—kidney cancer	7.01e-05	0.000382	CcSEcCtD
Indapamide—Diarrhoea—Dactinomycin—kidney cancer	6.99e-05	0.000381	CcSEcCtD
Indapamide—Nasopharyngitis—Doxorubicin—kidney cancer	6.98e-05	0.00038	CcSEcCtD
Indapamide—Anorexia—Paclitaxel—kidney cancer	6.91e-05	0.000376	CcSEcCtD
Indapamide—Gastritis—Doxorubicin—kidney cancer	6.91e-05	0.000376	CcSEcCtD
Indapamide—CA5A—Metabolism—CA9—kidney cancer	6.89e-05	0.000884	CbGpPWpGaD
Indapamide—Muscular weakness—Doxorubicin—kidney cancer	6.88e-05	0.000375	CcSEcCtD
Indapamide—CA9—Metabolism—CCBL1—kidney cancer	6.88e-05	0.000882	CbGpPWpGaD
Indapamide—CA12—Metabolism—LDHB—kidney cancer	6.88e-05	0.000882	CbGpPWpGaD
Indapamide—Vision blurred—Capecitabine—kidney cancer	6.87e-05	0.000374	CcSEcCtD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	6.87e-05	0.000881	CbGpPWpGaD
Indapamide—Vomiting—Sunitinib—kidney cancer	6.86e-05	0.000374	CcSEcCtD
Indapamide—CA4—Metabolism—APRT—kidney cancer	6.86e-05	0.000879	CbGpPWpGaD
Indapamide—CA4—Metabolism—FH—kidney cancer	6.86e-05	0.000879	CbGpPWpGaD
Indapamide—Body temperature increased—Gemcitabine—kidney cancer	6.85e-05	0.000373	CcSEcCtD
Indapamide—Rash—Sunitinib—kidney cancer	6.81e-05	0.000371	CcSEcCtD
Indapamide—Dermatitis—Sunitinib—kidney cancer	6.8e-05	0.00037	CcSEcCtD
Indapamide—Hypotension—Paclitaxel—kidney cancer	6.78e-05	0.000369	CcSEcCtD
Indapamide—Ill-defined disorder—Capecitabine—kidney cancer	6.77e-05	0.000368	CcSEcCtD
Indapamide—Headache—Sunitinib—kidney cancer	6.76e-05	0.000368	CcSEcCtD
Indapamide—Influenza—Doxorubicin—kidney cancer	6.75e-05	0.000367	CcSEcCtD
Indapamide—Asthma—Doxorubicin—kidney cancer	6.75e-05	0.000367	CcSEcCtD
Indapamide—Dysphagia—Doxorubicin—kidney cancer	6.75e-05	0.000367	CcSEcCtD
Indapamide—Anaemia—Capecitabine—kidney cancer	6.74e-05	0.000367	CcSEcCtD
Indapamide—Hypersensitivity—Vincristine—kidney cancer	6.73e-05	0.000366	CcSEcCtD
Indapamide—Nausea—Sorafenib—kidney cancer	6.66e-05	0.000363	CcSEcCtD
Indapamide—Pancreatitis—Doxorubicin—kidney cancer	6.61e-05	0.00036	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	6.61e-05	0.00036	CcSEcCtD
Indapamide—CA2—Metabolism—FH—kidney cancer	6.58e-05	0.000843	CbGpPWpGaD
Indapamide—CA2—Metabolism—APRT—kidney cancer	6.58e-05	0.000843	CbGpPWpGaD
Indapamide—Malaise—Capecitabine—kidney cancer	6.58e-05	0.000358	CcSEcCtD
Indapamide—Angina pectoris—Doxorubicin—kidney cancer	6.57e-05	0.000358	CcSEcCtD
Indapamide—Insomnia—Paclitaxel—kidney cancer	6.56e-05	0.000357	CcSEcCtD
Indapamide—Vertigo—Capecitabine—kidney cancer	6.55e-05	0.000357	CcSEcCtD
Indapamide—Asthenia—Vincristine—kidney cancer	6.55e-05	0.000357	CcSEcCtD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	6.54e-05	0.000839	CbGpPWpGaD
Indapamide—Syncope—Capecitabine—kidney cancer	6.54e-05	0.000356	CcSEcCtD
Indapamide—Leukopenia—Capecitabine—kidney cancer	6.53e-05	0.000355	CcSEcCtD
Indapamide—Paraesthesia—Paclitaxel—kidney cancer	6.51e-05	0.000355	CcSEcCtD
Indapamide—Vomiting—Dactinomycin—kidney cancer	6.5e-05	0.000354	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—kidney cancer	6.49e-05	0.000353	CcSEcCtD
Indapamide—Dyspnoea—Paclitaxel—kidney cancer	6.46e-05	0.000352	CcSEcCtD
Indapamide—CA4—Metabolism—GPC3—kidney cancer	6.45e-05	0.000827	CbGpPWpGaD
Indapamide—Somnolence—Paclitaxel—kidney cancer	6.45e-05	0.000351	CcSEcCtD
Indapamide—Palpitations—Capecitabine—kidney cancer	6.44e-05	0.000351	CcSEcCtD
Indapamide—Rash—Dactinomycin—kidney cancer	6.44e-05	0.000351	CcSEcCtD
Indapamide—CA5B—Metabolism—CA9—kidney cancer	6.44e-05	0.000825	CbGpPWpGaD
Indapamide—CA7—Metabolism—CA9—kidney cancer	6.44e-05	0.000825	CbGpPWpGaD
Indapamide—Nausea—Sunitinib—kidney cancer	6.41e-05	0.000349	CcSEcCtD
Indapamide—Loss of consciousness—Capecitabine—kidney cancer	6.41e-05	0.000349	CcSEcCtD
Indapamide—Dyspepsia—Paclitaxel—kidney cancer	6.38e-05	0.000348	CcSEcCtD
Indapamide—Cough—Capecitabine—kidney cancer	6.36e-05	0.000346	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—kidney cancer	6.31e-05	0.000343	CcSEcCtD
Indapamide—Decreased appetite—Paclitaxel—kidney cancer	6.3e-05	0.000343	CcSEcCtD
Indapamide—CA4—Metabolism—CA2—kidney cancer	6.27e-05	0.000804	CbGpPWpGaD
Indapamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	6.26e-05	0.000341	CcSEcCtD
Indapamide—Fatigue—Paclitaxel—kidney cancer	6.25e-05	0.00034	CcSEcCtD
Indapamide—Diarrhoea—Vincristine—kidney cancer	6.25e-05	0.00034	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—kidney cancer	6.23e-05	0.000339	CcSEcCtD
Indapamide—Asthenia—Gemcitabine—kidney cancer	6.21e-05	0.000338	CcSEcCtD
Indapamide—Chest pain—Capecitabine—kidney cancer	6.21e-05	0.000338	CcSEcCtD
Indapamide—Arthralgia—Capecitabine—kidney cancer	6.21e-05	0.000338	CcSEcCtD
Indapamide—Myalgia—Capecitabine—kidney cancer	6.21e-05	0.000338	CcSEcCtD
Indapamide—Pain—Paclitaxel—kidney cancer	6.2e-05	0.000338	CcSEcCtD
Indapamide—Constipation—Paclitaxel—kidney cancer	6.2e-05	0.000338	CcSEcCtD
Indapamide—Anxiety—Capecitabine—kidney cancer	6.19e-05	0.000337	CcSEcCtD
Indapamide—CA2—Metabolism—GPC3—kidney cancer	6.18e-05	0.000793	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—HIF1A—kidney cancer	6.17e-05	0.000791	CbGpPWpGaD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	6.16e-05	0.000336	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—kidney cancer	6.16e-05	0.000335	CcSEcCtD
Indapamide—Discomfort—Capecitabine—kidney cancer	6.13e-05	0.000334	CcSEcCtD
Indapamide—Pruritus—Gemcitabine—kidney cancer	6.13e-05	0.000334	CcSEcCtD
Indapamide—CA4—Metabolism—ALAD—kidney cancer	6.11e-05	0.000784	CbGpPWpGaD
Indapamide—Weight decreased—Doxorubicin—kidney cancer	6.1e-05	0.000332	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—kidney cancer	6.08e-05	0.000331	CcSEcCtD
Indapamide—Dry mouth—Capecitabine—kidney cancer	6.07e-05	0.000331	CcSEcCtD
Indapamide—Nausea—Dactinomycin—kidney cancer	6.07e-05	0.00033	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—MAPK1—kidney cancer	6.06e-05	0.000777	CbGpPWpGaD
Indapamide—Pneumonia—Doxorubicin—kidney cancer	6.05e-05	0.000329	CcSEcCtD
Indapamide—Dizziness—Vincristine—kidney cancer	6.04e-05	0.000329	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—kidney cancer	6.01e-05	0.000327	CcSEcCtD
Indapamide—Feeling abnormal—Paclitaxel—kidney cancer	5.98e-05	0.000325	CcSEcCtD
Indapamide—CA4—Metabolism—ST3GAL2—kidney cancer	5.97e-05	0.000765	CbGpPWpGaD
Indapamide—CA12—Metabolism—CA9—kidney cancer	5.96e-05	0.000764	CbGpPWpGaD
Indapamide—CA9—Metabolism—GLIPR1—kidney cancer	5.96e-05	0.000764	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPAT—kidney cancer	5.96e-05	0.000764	CbGpPWpGaD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	5.96e-05	0.000325	CcSEcCtD
Indapamide—Oedema—Capecitabine—kidney cancer	5.95e-05	0.000324	CcSEcCtD
Indapamide—Gastrointestinal pain—Paclitaxel—kidney cancer	5.93e-05	0.000323	CcSEcCtD
Indapamide—Diarrhoea—Gemcitabine—kidney cancer	5.93e-05	0.000323	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—kidney cancer	5.91e-05	0.000322	CcSEcCtD
Indapamide—Infection—Capecitabine—kidney cancer	5.91e-05	0.000322	CcSEcCtD
Indapamide—CA5A—Metabolism—CRABP1—kidney cancer	5.86e-05	0.000752	CbGpPWpGaD
Indapamide—CA2—Metabolism—ALAD—kidney cancer	5.86e-05	0.000752	CbGpPWpGaD
Indapamide—Jaundice—Doxorubicin—kidney cancer	5.86e-05	0.000319	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—kidney cancer	5.86e-05	0.000319	CcSEcCtD
Indapamide—Shock—Capecitabine—kidney cancer	5.85e-05	0.000319	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—kidney cancer	5.85e-05	0.000318	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—kidney cancer	5.85e-05	0.000318	CcSEcCtD
Indapamide—Nervous system disorder—Capecitabine—kidney cancer	5.84e-05	0.000318	CcSEcCtD
Indapamide—CA4—Metabolism—ALDH1A1—kidney cancer	5.83e-05	0.000748	CbGpPWpGaD
Indapamide—Thrombocytopenia—Capecitabine—kidney cancer	5.83e-05	0.000317	CcSEcCtD
Indapamide—Tachycardia—Capecitabine—kidney cancer	5.81e-05	0.000316	CcSEcCtD
Indapamide—Vomiting—Vincristine—kidney cancer	5.8e-05	0.000316	CcSEcCtD
Indapamide—Skin disorder—Capecitabine—kidney cancer	5.78e-05	0.000315	CcSEcCtD
Indapamide—Sweating—Doxorubicin—kidney cancer	5.77e-05	0.000314	CcSEcCtD
Indapamide—Urticaria—Paclitaxel—kidney cancer	5.76e-05	0.000314	CcSEcCtD
Indapamide—Rash—Vincristine—kidney cancer	5.76e-05	0.000313	CcSEcCtD
Indapamide—Hyperhidrosis—Capecitabine—kidney cancer	5.75e-05	0.000313	CcSEcCtD
Indapamide—Dermatitis—Vincristine—kidney cancer	5.75e-05	0.000313	CcSEcCtD
Indapamide—Body temperature increased—Paclitaxel—kidney cancer	5.73e-05	0.000312	CcSEcCtD
Indapamide—Abdominal pain—Paclitaxel—kidney cancer	5.73e-05	0.000312	CcSEcCtD
Indapamide—CA2—Metabolism—ST3GAL2—kidney cancer	5.72e-05	0.000734	CbGpPWpGaD
Indapamide—Headache—Vincristine—kidney cancer	5.72e-05	0.000311	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—kidney cancer	5.69e-05	0.00031	CcSEcCtD
Indapamide—Anorexia—Capecitabine—kidney cancer	5.67e-05	0.000309	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—kidney cancer	5.64e-05	0.000307	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—kidney cancer	5.61e-05	0.000306	CcSEcCtD
Indapamide—CA2—Metabolism—ALDH1A1—kidney cancer	5.59e-05	0.000717	CbGpPWpGaD
Indapamide—CA4—Metabolism—PGK1—kidney cancer	5.59e-05	0.000717	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC5A3—kidney cancer	5.59e-05	0.000717	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—ABCB1—kidney cancer	5.57e-05	0.000714	CbGpPWpGaD
Indapamide—Hypotension—Capecitabine—kidney cancer	5.56e-05	0.000303	CcSEcCtD
Indapamide—CA9—Metabolism—FH—kidney cancer	5.54e-05	0.000711	CbGpPWpGaD
Indapamide—CA9—Metabolism—APRT—kidney cancer	5.54e-05	0.000711	CbGpPWpGaD
Indapamide—Vomiting—Gemcitabine—kidney cancer	5.51e-05	0.0003	CcSEcCtD
Indapamide—CA4—Metabolism—LDHB—kidney cancer	5.48e-05	0.000703	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CRABP1—kidney cancer	5.47e-05	0.000702	CbGpPWpGaD
Indapamide—CA7—Metabolism—CRABP1—kidney cancer	5.47e-05	0.000702	CbGpPWpGaD
Indapamide—Rash—Gemcitabine—kidney cancer	5.46e-05	0.000297	CcSEcCtD
Indapamide—Dermatitis—Gemcitabine—kidney cancer	5.46e-05	0.000297	CcSEcCtD
Indapamide—CA5A—Metabolism—ITPR2—kidney cancer	5.45e-05	0.000699	CbGpPWpGaD
Indapamide—Headache—Gemcitabine—kidney cancer	5.43e-05	0.000295	CcSEcCtD
Indapamide—Nausea—Vincristine—kidney cancer	5.42e-05	0.000295	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	5.42e-05	0.000295	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—kidney cancer	5.41e-05	0.000295	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—kidney cancer	5.4e-05	0.000294	CcSEcCtD
Indapamide—Insomnia—Capecitabine—kidney cancer	5.38e-05	0.000293	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—kidney cancer	5.37e-05	0.000293	CcSEcCtD
Indapamide—CA2—Metabolism—PGK1—kidney cancer	5.36e-05	0.000687	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC5A3—kidney cancer	5.36e-05	0.000687	CbGpPWpGaD
Indapamide—Pharyngitis—Doxorubicin—kidney cancer	5.36e-05	0.000292	CcSEcCtD
Indapamide—Paraesthesia—Capecitabine—kidney cancer	5.34e-05	0.000291	CcSEcCtD
Indapamide—Hypersensitivity—Paclitaxel—kidney cancer	5.34e-05	0.000291	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—kidney cancer	5.33e-05	0.00029	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—kidney cancer	5.32e-05	0.00029	CcSEcCtD
Indapamide—Dyspnoea—Capecitabine—kidney cancer	5.31e-05	0.000289	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—kidney cancer	5.29e-05	0.000288	CcSEcCtD
Indapamide—CA2—Metabolism—LDHB—kidney cancer	5.26e-05	0.000674	CbGpPWpGaD
Indapamide—Dyspepsia—Capecitabine—kidney cancer	5.24e-05	0.000285	CcSEcCtD
Indapamide—CA9—Metabolism—GPC3—kidney cancer	5.21e-05	0.000668	CbGpPWpGaD
Indapamide—Visual impairment—Doxorubicin—kidney cancer	5.2e-05	0.000283	CcSEcCtD
Indapamide—Asthenia—Paclitaxel—kidney cancer	5.2e-05	0.000283	CcSEcCtD
Indapamide—Decreased appetite—Capecitabine—kidney cancer	5.17e-05	0.000282	CcSEcCtD
Indapamide—Nausea—Gemcitabine—kidney cancer	5.14e-05	0.00028	CcSEcCtD
Indapamide—Gastrointestinal disorder—Capecitabine—kidney cancer	5.14e-05	0.00028	CcSEcCtD
Indapamide—Fatigue—Capecitabine—kidney cancer	5.13e-05	0.000279	CcSEcCtD
Indapamide—Pruritus—Paclitaxel—kidney cancer	5.13e-05	0.000279	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—kidney cancer	5.1e-05	0.000278	CcSEcCtD
Indapamide—Constipation—Capecitabine—kidney cancer	5.09e-05	0.000277	CcSEcCtD
Indapamide—Pain—Capecitabine—kidney cancer	5.09e-05	0.000277	CcSEcCtD
Indapamide—CA7—Metabolism—ITPR2—kidney cancer	5.09e-05	0.000652	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ITPR2—kidney cancer	5.09e-05	0.000652	CbGpPWpGaD
Indapamide—CA9—Metabolism—CA2—kidney cancer	5.07e-05	0.00065	CbGpPWpGaD
Indapamide—CA12—Metabolism—CRABP1—kidney cancer	5.07e-05	0.00065	CbGpPWpGaD
Indapamide—Tinnitus—Doxorubicin—kidney cancer	5.03e-05	0.000274	CcSEcCtD
Indapamide—Flushing—Doxorubicin—kidney cancer	5.01e-05	0.000273	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—kidney cancer	5.01e-05	0.000273	CcSEcCtD
Indapamide—CA5A—Metabolism—GSTT1—kidney cancer	4.97e-05	0.000637	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ACHE—kidney cancer	4.97e-05	0.000637	CbGpPWpGaD
Indapamide—Diarrhoea—Paclitaxel—kidney cancer	4.96e-05	0.00027	CcSEcCtD
Indapamide—CA9—Metabolism—ALAD—kidney cancer	4.94e-05	0.000633	CbGpPWpGaD
Indapamide—Feeling abnormal—Capecitabine—kidney cancer	4.9e-05	0.000267	CcSEcCtD
Indapamide—Gastrointestinal pain—Capecitabine—kidney cancer	4.87e-05	0.000265	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—kidney cancer	4.82e-05	0.000263	CcSEcCtD
Indapamide—CA9—Metabolism—ST3GAL2—kidney cancer	4.82e-05	0.000618	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	4.81e-05	0.000617	CbGpPWpGaD
Indapamide—Dizziness—Paclitaxel—kidney cancer	4.8e-05	0.000261	CcSEcCtD
Indapamide—CA4—Metabolism—CA9—kidney cancer	4.76e-05	0.00061	CbGpPWpGaD
Indapamide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.73e-05	0.000606	CbGpPWpGaD
Indapamide—Urticaria—Capecitabine—kidney cancer	4.73e-05	0.000257	CcSEcCtD
Indapamide—CA9—Metabolism—ALDH1A1—kidney cancer	4.71e-05	0.000604	CbGpPWpGaD
Indapamide—CA12—Metabolism—ITPR2—kidney cancer	4.71e-05	0.000604	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SCARB1—kidney cancer	4.7e-05	0.000603	CbGpPWpGaD
Indapamide—Body temperature increased—Capecitabine—kidney cancer	4.7e-05	0.000256	CcSEcCtD
Indapamide—Abdominal pain—Capecitabine—kidney cancer	4.7e-05	0.000256	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—kidney cancer	4.7e-05	0.000256	CcSEcCtD
Indapamide—Erythema—Doxorubicin—kidney cancer	4.7e-05	0.000256	CcSEcCtD
Indapamide—CA5A—Metabolism—PTGS1—kidney cancer	4.66e-05	0.000597	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.64e-05	0.000595	CbGpPWpGaD
Indapamide—CA7—Metabolism—ACHE—kidney cancer	4.64e-05	0.000595	CbGpPWpGaD
Indapamide—CA5B—Metabolism—ACHE—kidney cancer	4.64e-05	0.000595	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTT1—kidney cancer	4.64e-05	0.000595	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTT1—kidney cancer	4.64e-05	0.000595	CbGpPWpGaD
Indapamide—Flatulence—Doxorubicin—kidney cancer	4.63e-05	0.000252	CcSEcCtD
Indapamide—Tension—Doxorubicin—kidney cancer	4.61e-05	0.000251	CcSEcCtD
Indapamide—Vomiting—Paclitaxel—kidney cancer	4.61e-05	0.000251	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—kidney cancer	4.6e-05	0.000251	CcSEcCtD
Indapamide—Rash—Paclitaxel—kidney cancer	4.57e-05	0.000249	CcSEcCtD
Indapamide—Dermatitis—Paclitaxel—kidney cancer	4.57e-05	0.000249	CcSEcCtD
Indapamide—CA5A—Metabolism—PSMD7—kidney cancer	4.57e-05	0.000585	CbGpPWpGaD
Indapamide—Nervousness—Doxorubicin—kidney cancer	4.56e-05	0.000249	CcSEcCtD
Indapamide—CA2—Metabolism—CA9—kidney cancer	4.56e-05	0.000584	CbGpPWpGaD
Indapamide—Back pain—Doxorubicin—kidney cancer	4.55e-05	0.000248	CcSEcCtD
Indapamide—Headache—Paclitaxel—kidney cancer	4.54e-05	0.000247	CcSEcCtD
Indapamide—CA9—Metabolism—PGK1—kidney cancer	4.52e-05	0.000579	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC5A3—kidney cancer	4.52e-05	0.000579	CbGpPWpGaD
Indapamide—Muscle spasms—Doxorubicin—kidney cancer	4.52e-05	0.000246	CcSEcCtD
Indapamide—CA9—Metabolism—LDHB—kidney cancer	4.43e-05	0.000568	CbGpPWpGaD
Indapamide—Vision blurred—Doxorubicin—kidney cancer	4.43e-05	0.000241	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDKN2A—kidney cancer	4.42e-05	0.000566	CbGpPWpGaD
Indapamide—CA7—Metabolism—SCARB1—kidney cancer	4.39e-05	0.000563	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SCARB1—kidney cancer	4.39e-05	0.000563	CbGpPWpGaD
Indapamide—Hypersensitivity—Capecitabine—kidney cancer	4.38e-05	0.000239	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—kidney cancer	4.36e-05	0.000237	CcSEcCtD
Indapamide—CA5B—Metabolism—PTGS1—kidney cancer	4.35e-05	0.000557	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS1—kidney cancer	4.35e-05	0.000557	CbGpPWpGaD
Indapamide—Anaemia—Doxorubicin—kidney cancer	4.34e-05	0.000237	CcSEcCtD
Indapamide—CA5A—Metabolism—BCHE—kidney cancer	4.33e-05	0.000555	CbGpPWpGaD
Indapamide—Agitation—Doxorubicin—kidney cancer	4.32e-05	0.000235	CcSEcCtD
Indapamide—Nausea—Paclitaxel—kidney cancer	4.31e-05	0.000235	CcSEcCtD
Indapamide—CA12—Metabolism—GSTT1—kidney cancer	4.3e-05	0.000551	CbGpPWpGaD
Indapamide—CA12—Metabolism—ACHE—kidney cancer	4.3e-05	0.000551	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC5A5—kidney cancer	4.28e-05	0.000548	CbGpPWpGaD
Indapamide—Asthenia—Capecitabine—kidney cancer	4.27e-05	0.000232	CcSEcCtD
Indapamide—CA5B—Metabolism—PSMD7—kidney cancer	4.26e-05	0.000547	CbGpPWpGaD
Indapamide—CA7—Metabolism—PSMD7—kidney cancer	4.26e-05	0.000547	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—RELA—kidney cancer	4.25e-05	0.000545	CbGpPWpGaD
Indapamide—Malaise—Doxorubicin—kidney cancer	4.24e-05	0.000231	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—kidney cancer	4.22e-05	0.00023	CcSEcCtD
Indapamide—Syncope—Doxorubicin—kidney cancer	4.21e-05	0.00023	CcSEcCtD
Indapamide—Pruritus—Capecitabine—kidney cancer	4.21e-05	0.000229	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—kidney cancer	4.21e-05	0.000229	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—MTOR—kidney cancer	4.17e-05	0.000534	CbGpPWpGaD
Indapamide—Palpitations—Doxorubicin—kidney cancer	4.15e-05	0.000226	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—kidney cancer	4.13e-05	0.000225	CcSEcCtD
Indapamide—CA5A—Metabolism—SLC2A1—kidney cancer	4.13e-05	0.000529	CbGpPWpGaD
Indapamide—Cough—Doxorubicin—kidney cancer	4.1e-05	0.000223	CcSEcCtD
Indapamide—Diarrhoea—Capecitabine—kidney cancer	4.07e-05	0.000222	CcSEcCtD
Indapamide—CA12—Metabolism—SCARB1—kidney cancer	4.07e-05	0.000522	CbGpPWpGaD
Indapamide—CA4—Metabolism—CRABP1—kidney cancer	4.04e-05	0.000518	CbGpPWpGaD
Indapamide—CA7—Metabolism—BCHE—kidney cancer	4.04e-05	0.000518	CbGpPWpGaD
Indapamide—CA5B—Metabolism—BCHE—kidney cancer	4.04e-05	0.000518	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS1—kidney cancer	4.03e-05	0.000516	CbGpPWpGaD
Indapamide—Arthralgia—Doxorubicin—kidney cancer	4e-05	0.000218	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—kidney cancer	4e-05	0.000218	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—kidney cancer	4e-05	0.000218	CcSEcCtD
Indapamide—CA7—Metabolism—SLC5A5—kidney cancer	3.99e-05	0.000512	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC5A5—kidney cancer	3.99e-05	0.000512	CbGpPWpGaD
Indapamide—Anxiety—Doxorubicin—kidney cancer	3.99e-05	0.000217	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.97e-05	0.000216	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—kidney cancer	3.95e-05	0.000215	CcSEcCtD
Indapamide—CA12—Metabolism—PSMD7—kidney cancer	3.95e-05	0.000506	CbGpPWpGaD
Indapamide—Dizziness—Capecitabine—kidney cancer	3.94e-05	0.000214	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—kidney cancer	3.91e-05	0.000213	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—CDKN1B—kidney cancer	3.91e-05	0.000501	CbGpPWpGaD
Indapamide—CA2—Metabolism—CRABP1—kidney cancer	3.88e-05	0.000497	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC2A1—kidney cancer	3.86e-05	0.000494	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC2A1—kidney cancer	3.86e-05	0.000494	CbGpPWpGaD
Indapamide—Oedema—Doxorubicin—kidney cancer	3.84e-05	0.000209	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—kidney cancer	3.84e-05	0.000209	CcSEcCtD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.82e-05	0.00049	CbGpPWpGaD
Indapamide—Infection—Doxorubicin—kidney cancer	3.81e-05	0.000208	CcSEcCtD
Indapamide—Vomiting—Capecitabine—kidney cancer	3.78e-05	0.000206	CcSEcCtD
Indapamide—Shock—Doxorubicin—kidney cancer	3.77e-05	0.000205	CcSEcCtD
Indapamide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.77e-05	0.000484	CbGpPWpGaD
Indapamide—Nervous system disorder—Doxorubicin—kidney cancer	3.76e-05	0.000205	CcSEcCtD
Indapamide—CA4—Metabolism—ITPR2—kidney cancer	3.76e-05	0.000482	CbGpPWpGaD
Indapamide—Thrombocytopenia—Doxorubicin—kidney cancer	3.76e-05	0.000205	CcSEcCtD
Indapamide—Rash—Capecitabine—kidney cancer	3.75e-05	0.000204	CcSEcCtD
Indapamide—Dermatitis—Capecitabine—kidney cancer	3.75e-05	0.000204	CcSEcCtD
Indapamide—CA12—Metabolism—BCHE—kidney cancer	3.74e-05	0.00048	CbGpPWpGaD
Indapamide—Tachycardia—Doxorubicin—kidney cancer	3.74e-05	0.000204	CcSEcCtD
Indapamide—Headache—Capecitabine—kidney cancer	3.73e-05	0.000203	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—kidney cancer	3.73e-05	0.000203	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—JUN—kidney cancer	3.72e-05	0.000477	CbGpPWpGaD
Indapamide—Hyperhidrosis—Doxorubicin—kidney cancer	3.71e-05	0.000202	CcSEcCtD
Indapamide—CA12—Metabolism—SLC5A5—kidney cancer	3.7e-05	0.000474	CbGpPWpGaD
Indapamide—Anorexia—Doxorubicin—kidney cancer	3.66e-05	0.000199	CcSEcCtD
Indapamide—CA2—Metabolism—ITPR2—kidney cancer	3.6e-05	0.000462	CbGpPWpGaD
Indapamide—Hypotension—Doxorubicin—kidney cancer	3.58e-05	0.000195	CcSEcCtD
Indapamide—CA12—Metabolism—SLC2A1—kidney cancer	3.57e-05	0.000458	CbGpPWpGaD
Indapamide—Nausea—Capecitabine—kidney cancer	3.53e-05	0.000192	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.49e-05	0.00019	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—kidney cancer	3.47e-05	0.000189	CcSEcCtD
Indapamide—CA5A—Metabolism—GSTP1—kidney cancer	3.44e-05	0.000442	CbGpPWpGaD
Indapamide—Paraesthesia—Doxorubicin—kidney cancer	3.44e-05	0.000188	CcSEcCtD
Indapamide—CA4—Metabolism—GSTT1—kidney cancer	3.43e-05	0.000439	CbGpPWpGaD
Indapamide—CA4—Metabolism—ACHE—kidney cancer	3.43e-05	0.000439	CbGpPWpGaD
Indapamide—Dyspnoea—Doxorubicin—kidney cancer	3.42e-05	0.000186	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—kidney cancer	3.41e-05	0.000186	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—kidney cancer	3.38e-05	0.000184	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—kidney cancer	3.33e-05	0.000182	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.31e-05	0.00018	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—kidney cancer	3.31e-05	0.00018	CcSEcCtD
Indapamide—CA2—Metabolism—GSTT1—kidney cancer	3.29e-05	0.000421	CbGpPWpGaD
Indapamide—CA2—Metabolism—ACHE—kidney cancer	3.29e-05	0.000421	CbGpPWpGaD
Indapamide—Constipation—Doxorubicin—kidney cancer	3.28e-05	0.000179	CcSEcCtD
Indapamide—Pain—Doxorubicin—kidney cancer	3.28e-05	0.000179	CcSEcCtD
Indapamide—CA9—Metabolism—CRABP1—kidney cancer	3.27e-05	0.000419	CbGpPWpGaD
Indapamide—CA5A—Metabolism—ABCB1—kidney cancer	3.26e-05	0.000418	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—VEGFA—kidney cancer	3.25e-05	0.000417	CbGpPWpGaD
Indapamide—CA4—Metabolism—SCARB1—kidney cancer	3.24e-05	0.000416	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTP1—kidney cancer	3.22e-05	0.000412	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTP1—kidney cancer	3.22e-05	0.000412	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS1—kidney cancer	3.21e-05	0.000412	CbGpPWpGaD
Indapamide—CA5A—Metabolism—GSTM1—kidney cancer	3.17e-05	0.000406	CbGpPWpGaD
Indapamide—Feeling abnormal—Doxorubicin—kidney cancer	3.16e-05	0.000172	CcSEcCtD
Indapamide—CA4—Metabolism—PSMD7—kidney cancer	3.15e-05	0.000404	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RAF1—kidney cancer	3.15e-05	0.000404	CbGpPWpGaD
Indapamide—Gastrointestinal pain—Doxorubicin—kidney cancer	3.14e-05	0.000171	CcSEcCtD
Indapamide—CA2—Metabolism—SCARB1—kidney cancer	3.11e-05	0.000399	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.1e-05	0.000397	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS1—kidney cancer	3.08e-05	0.000395	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK3—kidney cancer	3.08e-05	0.000394	CbGpPWpGaD
Indapamide—Urticaria—Doxorubicin—kidney cancer	3.05e-05	0.000166	CcSEcCtD
Indapamide—CA5B—Metabolism—ABCB1—kidney cancer	3.04e-05	0.00039	CbGpPWpGaD
Indapamide—CA7—Metabolism—ABCB1—kidney cancer	3.04e-05	0.00039	CbGpPWpGaD
Indapamide—CA9—Metabolism—ITPR2—kidney cancer	3.04e-05	0.000389	CbGpPWpGaD
Indapamide—Body temperature increased—Doxorubicin—kidney cancer	3.03e-05	0.000165	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—kidney cancer	3.03e-05	0.000165	CcSEcCtD
Indapamide—CA2—Metabolism—PSMD7—kidney cancer	3.02e-05	0.000387	CbGpPWpGaD
Indapamide—CA5A—Metabolism—CYP1A1—kidney cancer	3e-05	0.000385	CbGpPWpGaD
Indapamide—CA4—Metabolism—BCHE—kidney cancer	2.99e-05	0.000383	CbGpPWpGaD
Indapamide—CA12—Metabolism—GSTP1—kidney cancer	2.98e-05	0.000382	CbGpPWpGaD
Indapamide—CA7—Metabolism—GSTM1—kidney cancer	2.96e-05	0.000379	CbGpPWpGaD
Indapamide—CA5B—Metabolism—GSTM1—kidney cancer	2.96e-05	0.000379	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC5A5—kidney cancer	2.95e-05	0.000378	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—MAPK1—kidney cancer	2.93e-05	0.000375	CbGpPWpGaD
Indapamide—CA2—Metabolism—BCHE—kidney cancer	2.86e-05	0.000367	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.85e-05	0.000365	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC2A1—kidney cancer	2.85e-05	0.000365	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC5A5—kidney cancer	2.83e-05	0.000363	CbGpPWpGaD
Indapamide—Hypersensitivity—Doxorubicin—kidney cancer	2.83e-05	0.000154	CcSEcCtD
Indapamide—CA12—Metabolism—ABCB1—kidney cancer	2.82e-05	0.000362	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CYP1A1—kidney cancer	2.8e-05	0.000359	CbGpPWpGaD
Indapamide—CA7—Metabolism—CYP1A1—kidney cancer	2.8e-05	0.000359	CbGpPWpGaD
Indapamide—CA9—Metabolism—ACHE—kidney cancer	2.77e-05	0.000355	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTT1—kidney cancer	2.77e-05	0.000355	CbGpPWpGaD
Indapamide—Asthenia—Doxorubicin—kidney cancer	2.75e-05	0.00015	CcSEcCtD
Indapamide—CA12—Metabolism—GSTM1—kidney cancer	2.74e-05	0.000351	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC2A1—kidney cancer	2.73e-05	0.00035	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.73e-05	0.00035	CbGpPWpGaD
Indapamide—Pruritus—Doxorubicin—kidney cancer	2.71e-05	0.000148	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—kidney cancer	2.62e-05	0.000143	CcSEcCtD
Indapamide—CA9—Metabolism—SCARB1—kidney cancer	2.62e-05	0.000336	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS1—kidney cancer	2.6e-05	0.000333	CbGpPWpGaD
Indapamide—CA12—Metabolism—CYP1A1—kidney cancer	2.6e-05	0.000333	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.56e-05	0.000328	CbGpPWpGaD
Indapamide—CA9—Metabolism—PSMD7—kidney cancer	2.55e-05	0.000326	CbGpPWpGaD
Indapamide—Dizziness—Doxorubicin—kidney cancer	2.54e-05	0.000138	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—TP53—kidney cancer	2.46e-05	0.000315	CbGpPWpGaD
Indapamide—Vomiting—Doxorubicin—kidney cancer	2.44e-05	0.000133	CcSEcCtD
Indapamide—Rash—Doxorubicin—kidney cancer	2.42e-05	0.000132	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—kidney cancer	2.42e-05	0.000132	CcSEcCtD
Indapamide—CA9—Metabolism—BCHE—kidney cancer	2.41e-05	0.000309	CbGpPWpGaD
Indapamide—Headache—Doxorubicin—kidney cancer	2.4e-05	0.000131	CcSEcCtD
Indapamide—CA9—Metabolism—SLC5A5—kidney cancer	2.38e-05	0.000306	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTP1—kidney cancer	2.38e-05	0.000305	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.31e-05	0.000296	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC2A1—kidney cancer	2.3e-05	0.000295	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—kidney cancer	2.28e-05	0.000124	CcSEcCtD
Indapamide—CA2—Metabolism—GSTP1—kidney cancer	2.28e-05	0.000292	CbGpPWpGaD
Indapamide—CA4—Metabolism—ABCB1—kidney cancer	2.25e-05	0.000288	CbGpPWpGaD
Indapamide—CA5A—Metabolism—POMC—kidney cancer	2.24e-05	0.000287	CbGpPWpGaD
Indapamide—CA4—Metabolism—GSTM1—kidney cancer	2.18e-05	0.00028	CbGpPWpGaD
Indapamide—CA2—Metabolism—ABCB1—kidney cancer	2.16e-05	0.000276	CbGpPWpGaD
Indapamide—CA2—Metabolism—GSTM1—kidney cancer	2.09e-05	0.000268	CbGpPWpGaD
Indapamide—CA7—Metabolism—POMC—kidney cancer	2.09e-05	0.000268	CbGpPWpGaD
Indapamide—CA5B—Metabolism—POMC—kidney cancer	2.09e-05	0.000268	CbGpPWpGaD
Indapamide—CA4—Metabolism—CYP1A1—kidney cancer	2.07e-05	0.000265	CbGpPWpGaD
Indapamide—CA2—Metabolism—CYP1A1—kidney cancer	1.98e-05	0.000254	CbGpPWpGaD
Indapamide—CA12—Metabolism—POMC—kidney cancer	1.94e-05	0.000248	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTP1—kidney cancer	1.92e-05	0.000246	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.89e-05	0.000242	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.86e-05	0.000239	CbGpPWpGaD
Indapamide—CA9—Metabolism—ABCB1—kidney cancer	1.82e-05	0.000233	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—kidney cancer	1.78e-05	0.000229	CbGpPWpGaD
Indapamide—CA9—Metabolism—GSTM1—kidney cancer	1.76e-05	0.000226	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.74e-05	0.000223	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.71e-05	0.00022	CbGpPWpGaD
Indapamide—CA9—Metabolism—CYP1A1—kidney cancer	1.67e-05	0.000214	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—kidney cancer	1.67e-05	0.000214	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—kidney cancer	1.67e-05	0.000214	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.65e-05	0.000211	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.62e-05	0.000208	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—kidney cancer	1.56e-05	0.0002	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—kidney cancer	1.54e-05	0.000198	CbGpPWpGaD
Indapamide—CA4—Metabolism—POMC—kidney cancer	1.54e-05	0.000198	CbGpPWpGaD
Indapamide—CA2—Metabolism—POMC—kidney cancer	1.48e-05	0.00019	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—kidney cancer	1.45e-05	0.000186	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—kidney cancer	1.45e-05	0.000186	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACY1—kidney cancer	1.45e-05	0.000186	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—kidney cancer	1.35e-05	0.000173	CbGpPWpGaD
Indapamide—CA9—Metabolism—POMC—kidney cancer	1.25e-05	0.00016	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PDHB—kidney cancer	1.23e-05	0.000158	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—kidney cancer	1.23e-05	0.000158	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—POMC—kidney cancer	1.23e-05	0.000157	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—kidney cancer	1.18e-05	0.000151	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CCBL1—kidney cancer	1.16e-05	0.000148	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PIK3CA—kidney cancer	1.1e-05	0.000141	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—kidney cancer	1.07e-05	0.000138	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—kidney cancer	1.03e-05	0.000132	CbGpPWpGaD
Indapamide—CA7—Metabolism—PIK3CA—kidney cancer	1.03e-05	0.000131	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PIK3CA—kidney cancer	1.03e-05	0.000131	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPAT—kidney cancer	1e-05	0.000129	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	1e-05	0.000129	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—kidney cancer	9.95e-06	0.000128	CbGpPWpGaD
Indapamide—CA12—Metabolism—PIK3CA—kidney cancer	9.5e-06	0.000122	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—FH—kidney cancer	9.33e-06	0.00012	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—APRT—kidney cancer	9.33e-06	0.00012	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GPC3—kidney cancer	8.77e-06	0.000112	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—kidney cancer	8.67e-06	0.000111	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA2—kidney cancer	8.54e-06	0.000109	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALAD—kidney cancer	8.32e-06	0.000107	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.12e-06	0.000104	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.94e-06	0.000102	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PGK1—kidney cancer	7.61e-06	9.75e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.61e-06	9.75e-05	CbGpPWpGaD
Indapamide—CA4—Metabolism—PIK3CA—kidney cancer	7.57e-06	9.71e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—LDHB—kidney cancer	7.46e-06	9.56e-05	CbGpPWpGaD
Indapamide—CA2—Metabolism—PIK3CA—kidney cancer	7.26e-06	9.31e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CA9—kidney cancer	6.47e-06	8.29e-05	CbGpPWpGaD
Indapamide—CA9—Metabolism—PIK3CA—kidney cancer	6.12e-06	7.84e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CRABP1—kidney cancer	5.5e-06	7.05e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ITPR2—kidney cancer	5.11e-06	6.56e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ACHE—kidney cancer	4.66e-06	5.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTT1—kidney cancer	4.66e-06	5.98e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SCARB1—kidney cancer	4.41e-06	5.66e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS1—kidney cancer	4.37e-06	5.6e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PSMD7—kidney cancer	4.29e-06	5.49e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—BCHE—kidney cancer	4.06e-06	5.21e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.01e-06	5.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.88e-06	4.97e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTP1—kidney cancer	3.23e-06	4.14e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—ABCB1—kidney cancer	3.06e-06	3.92e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—GSTM1—kidney cancer	2.97e-06	3.81e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.82e-06	3.61e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—POMC—kidney cancer	2.1e-06	2.69e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—kidney cancer	1.67e-06	2.15e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—kidney cancer	1.46e-06	1.87e-05	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.03e-06	1.32e-05	CbGpPWpGaD
